cilostazol and uric acid

cilostazol has been researched along with uric acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, C; Kawamori, R; Kawasumi, M; Kubo, S; Mitsuhashi, N; Ogawa, S; Onuma, T; Shimizu, T; Tanaka, Y; Uchino, H; Watada, H1
Bushnell, CD; Han, SW; Kim, GS; Kim, OJ; Kim, SH; Koh, IS; Lee, JH; Lee, JY; Lee, KY; Lee, SI; Lee, SS; Nam, HS; Park, JH; Song, TJ; Suk, SH1

Trials

2 trial(s) available for cilostazol and uric acid

ArticleYear
Effect of cilostazol, a phosphodiesterase inhibitor, on carotid IMT in Japanese type 2 diabetic patients.
    Endocrine journal, 2004, Volume: 51, Issue:6

    Topics: Aged; Arteriosclerosis; Blood Pressure; Carotid Arteries; Cholesterol; Cilostazol; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Japan; Male; Middle Aged; Phosphodiesterase Inhibitors; Regression Analysis; Tetrazoles; Triglycerides; Tunica Intima; Ultrasonography; Uric Acid

2004
Serum Uric Acid Is Associated with Cerebral White Matter Hyperintensities in Patients with Acute Lacunar Infarction.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2016, Volume: 26, Issue:3

    Topics: Aged; Cilostazol; Double-Blind Method; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pulsatile Flow; Statistics as Topic; Stroke, Lacunar; Tetrazoles; Ultrasonography, Doppler, Transcranial; Uric Acid; White Matter

2016